SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 74 filers reported holding SILVERBACK THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $987,109 | -36.1% | 261,140 | +13.2% | 0.00% | – |
Q2 2023 | $1,545,630 | +229.9% | 230,691 | +220.5% | 0.00% | – |
Q1 2023 | $468,524 | -18.4% | 71,970 | +6.9% | 0.00% | – |
Q4 2022 | $574,094 | +177.3% | 67,303 | +71.3% | 0.00% | – |
Q3 2022 | $207,000 | +31.0% | 39,284 | +5.4% | 0.00% | – |
Q2 2022 | $158,000 | -74.1% | 37,260 | -78.5% | 0.00% | – |
Q1 2022 | $609,000 | -49.2% | 173,569 | -3.5% | 0.00% | – |
Q4 2021 | $1,198,000 | -35.3% | 179,858 | -3.2% | 0.00% | – |
Q3 2021 | $1,853,000 | -52.4% | 185,747 | +47.5% | 0.00% | -100.0% |
Q2 2021 | $3,890,000 | -33.8% | 125,898 | -6.5% | 0.00% | 0.0% |
Q1 2021 | $5,872,000 | – | 134,584 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Nextech Invest Ltd. | 1,910,029 | $12,721,000 | 3.35% |
Orbimed Advisors | 8,740,887 | $58,214,000 | 0.75% |
Nantahala Capital Management | 1,006,462 | $6,703,000 | 0.24% |
EcoR1 Capital, LLC | 1,060,010 | $7,060,000 | 0.22% |
Prosight Management, LP | 53,815 | $358,000 | 0.21% |
RA Capital Management | 1,742,186 | $11,603,000 | 0.20% |
Endurant Capital Management LP | 84,295 | $561,000 | 0.14% |
HighVista Strategies LLC | 22,434 | $149,000 | 0.12% |
XTX Topco Ltd | 18,816 | $125,000 | 0.07% |
WASATCH ADVISORS LP | 1,773,690 | $11,813,000 | 0.05% |